Trillium Shares Get Boost from Dose Escalation Trial Data and Pfizer's $25 Million Equity Investment
Source: Streetwise Reports  (9/9/20)
Trillium Therapeutics shares traded 37% higher after the company reported updated results from its ongoing TTI-622 and TTI-621 Dose Escalation Studies along with a $25 million equity investment from Pfizer Inc. More >

Biopharma Achieves 'Big Phase 3 Win' for its Pediatric Intrahepatic Cholestasis Drug
Source: Streetwise Reports  (9/9/20)
The recent study results of Albireo Pharma's lead therapeutic candidate are discussed in an H.C. Wainwright & Co. report. More >

Biotech Partners with University to Evaluate Psilocybin for Treating Methamphetamine Use Disorder
Source: Streetwise Reports  (9/4/20)
Revive Therapeutics reported it has entered into clinical trial agreement with the University of Wisconsin-Madison to evaluate the use of psilocybin for the treatment of methamphetamine use disorder. More >

Life Sciences Firm Gains Protocol Approval for Phase 3 COVID-19 Study
Source: Streetwise Reports  (9/2/20)
Revive Therapeutics reported that a renowned independent institutional review board has approved its proposed Phase 3 clinical trial protocol for Bucillamine in COVID-19. More >

Aimmune Therapeutics Shares Soar on Nestlé Health Science's $2.6 Billion Buyout
Source: Streetwise Reports  (8/31/20)
Aimmune Therapeutics shares traded 170% higher after the company reported it entered into a definitive agreement to be acquired by Nestlé for $34.50 per share in cash. More >

Firm Submits Clinical Protocol for IRB Approval for Phase 3 COVID-19 Trial
Source: Streetwise Reports  (8/28/20)
Revive Therapeutics reported it submitted the clinical protocol for independent Institutional Review Board approval for its Phase 3 study of Bucillamine in COVID-19. More >

VBI Shares Climb 34% After Identifying Two One-Dose COVID-19 Vaccine Candidates
Source: Streetwise Reports  (8/27/20)
VBI Vaccines shares traded higher after the company reported preclinical coronavirus program data and selection of clinical candidates with potential as one-dose vaccines. More >

Firm's Home Health Monitoring System Provides the 'Most Comprehensive Offering in the Telehealth Space'
Source: Streetwise Reports  (8/26/20)
As the Covid pandemic accelerates the adoption of telemedicine technology, Reliq Health Technologies' recent contracts represent exponential growth. More >

Fluidigm Shares Climb 34% After FDA Authorizes Saliva-Based COVID-19 Test
Source: Streetwise Reports  (8/26/20)
Fluidigm Corp. shares reached a new 52-week high after the firm reported the FDA granted Emergency Use Authorization for saliva-based Advanta Dx SARS-CoV-2 RT-PCR Assay for COVID-19. More >

CytoDyn Receives the UK's MHRA Approval for Phase 3 COVID-19 Study
Source: Streetwise Reports  (8/24/20)
CytoDyn Inc. shares traded higher after the company reported it received authorization from the U.K.'s MHRA to proceed with its Phase 3 study of leronlimab in patients with severe-to-critical COVID-19. More >

Cryoport to Acquire CRYOPDP for €49 Million to Expand Global Supply Chain
Source: Streetwise Reports  (8/21/20)
Shares of Cryoport Inc. reached a new 52-week high after the company reported it signed an agreement to acquire French firm CRYOPDP in an all cash transaction valued at €49 million. More >

CureVac Shares Rise on Talks with EC to Supply 405 Million mRNA-Based COVID-19 Vaccine Doses
Source: Streetwise Reports  (8/20/20)
CureVac NV shares traded 13% higher after the company reported it is in advanced discussions with the European Commission to supply up to 405 million doses of a potential mRNA-based COVID-19 vaccine. More >

Biotech Releases Positive Interim Results from Cystic Fibrosis Study
Source: Streetwise Reports  (8/19/20)
This and other recent key events of AzurRx BioPharma are recapped in a ROTH Capital Partners report. More >

California Biopharma to be Acquired by Sanofi for $3.6 Billion
Source: Streetwise Reports  (8/19/20)
The deal is summarized and Principia Biopharma's Q2/20 clinical achievements are recapped in an H.C. Wainwright & Co. report. More >

Momenta Pharmaceuticals Shares Rise 69% on $6.5 Billion Johnson & Johnson Takeover Bid
Source: Streetwise Reports  (8/19/20)
Shares of Momenta Pharmaceuticals set a new 52-week high after the company reported it entered into a definitive agreement with Johnson & Johnson to be acquired for $52.50 per share in cash. More >

Pharmaceutical Firm Enrolls First US Patient in Phase 2b/3 Ifenprodil COVID-19 Trial
Source: Streetwise Reports  (8/17/20)
Algernon Pharmaceuticals reported it has enrolled the first U.S. patient in its multinational Phase 2b/3 human study of Ifenprodil for use in treatment of SARS-CoV-2. More >

Canadian Biotech Advances Antibodies, Diagnostics Programs in Q2/20
Source: Streetwise Reports  (8/14/20)
One highlight is ProMIS Neurosciences' development of a SARS CoV-2 antibody test. More >

Telemedicine Firm Continues Expansion by Acquiring Majority Interest in Ontario Medical Clinic
Source: Streetwise Reports  (8/14/20)
The clinic will be integrated into the CloudMD EMR platform. More >

Mesoblast Shares Rocket Higher as FDA Committee Votes in Favor of Remestemcel-L for Pediatric SR-aGVHD Patients
Source: Streetwise Reports  (8/14/20)
Shares of Mesoblast Ltd. traded 50% higher after the company reported that the U.S. FDA's Oncologic Drugs Advisory Committee voted nine to one in favor of remestemcel-L (RYONCILâ„¢) for efficacy in children with steroid-refractory acute graft versus host disease. More >

Life Sciences Firm Signs MOU for Phase 3 COVID-19 Study
Source: Streetwise Reports  (8/14/20)
Revive Therapeutics reported it signed a MOU with Attwill Medical Solutions Sterilflow to be a clinical packaging and distribution resource for its Phase 3 clinical trial of Bucillamine in COVID-19. More >

Biotech Develops Oral Film Strips for Psychedelic Medicine Delivery
Source: Streetwise Reports  (8/12/20)
This development is a technical milestone for Revive Therapeutics and its drug delivery technology. More >

Pennant Group Shares Fly 40% Higher on Q2 Earnings and Raised FY Adjusted EPS Guidance
Source: Streetwise Reports  (8/12/20)
Shares of The Pennant Group reached a new 52-week high after the company reported a 12.1% increase in Q2/20 revenue and raised FY/20 adjusted EPS guidance by 34.2%. More >

Life Sciences Company Registers First Non-Antibiotic Livestock Feed Additive Sale in Brazil
Source: Streetwise Reports  (8/12/20)
Avivagen Inc. reported it achieved its first sale of OxC-betaâ„¢ Livestock in Brazil, the world's third largest livestock feed market. More >

Eyenovia Shares Look 38% Higher on Development Deal with Arctic Vision in Asia
Source: Streetwise Reports  (8/11/20)
Shares of Eyenovia Inc. set a new 52-week high after the firm reported it entered into an exclusive collaboration and license agreement with Arctic Vision to develop and market MicroPine and MicroLine in China and South Korea. More >

Seres Therapeutics Shares Go Parabolic on Positive Topline Data from Phase 3 C.Diff Trial
Source: Streetwise Reports  (8/10/20)
Seres Therapeutics shares traded 350% higher setting a new 52-week high after the firm reported positive topline results from its SER-109 Phase 3 ECOSPOR III study in recurrent C. difficile infection. More >